This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
Telecom Argentina (TEO) Soars 5.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Telecom Argentina (TEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TEONegative Net Change TLTZYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Uniti (UNIT) Soars 15.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Uniti (UNIT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
UNITNegative Net Change TMUSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Sotera Health (SHC) Soars 8.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Sotera Health (SHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SHCPositive Net Change TDOCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Viridian Therapeutics (VRDN) Soars 5.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Viridian Therapeutics (VRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
VRDNPositive Net Change MYGNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?
by Zacks Equity Research
Rhythm Pharmaceuticals (RYTM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RYTMNegative Net Change MRNAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?
by Zacks Equity Research
Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MIRMPositive Net Change OCGNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?
by Zacks Equity Research
Immunome (IMNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
IMNMPositive Net Change CTMXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last?
by Zacks Equity Research
Apellis Pharmaceuticals (APLS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AUTLPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Valmont (VMI) Surges 4.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Valmont (VMI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
VMIPositive Net Change TSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Perimeter Solutions, SA (PRM) Soars 14.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Perimeter Solutions, SA (PRM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PRMPositive Net Change IFFNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today